M-Xylene

M-Xylene

SCHEMBL5753970

Cc1cccc(C)c1.O=COCl

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 5/20 0.57
TP53 P04637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPK1 P28482 1/20 0.41
LMNA P02545 1/20 0.41
NPC1 O15118 1/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
PARP1 P09874 1/20 0.39
TSHR P16473 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
IDO1 P14902 2/20 0.38
RELA Q04206 1/20 0.37
FBP1 P09467 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
M-Xylene SCHEMBL27790156 0.83 ACHE (0.60) ACHETP53TDP1ALDH1A1MAPK1
Toluene SCHEMBL458351 0.83 LMNA (0.55) ACHEALDH1A1LMNANPC1TSHR
M-Xylene SCHEMBL25222375 0.82 ACHE (0.67) ACHETP53TDP1ALDH1A1MAPK1
M-Xylene SCHEMBL28804955 0.79 ACHE (0.71) ACHETP53TDP1ALDH1A1MAPK1
M-Xylene SCHEMBL28292894 0.77 ACHE (0.67) ACHETP53TDP1ALDH1A1MAPK1
M-Xylene SCHEMBL27973955 0.77 ACHE (0.67) ACHETP53TDP1ALDH1A1MAPK1
M-Xylene SCHEMBL891494 0.76 ACHE (1.00) ACHETP53TDP1ALDH1A1MAPK1
M-Xylene SCHEMBL6397624 0.76
M-Xylene SCHEMBL28189 0.76
M-Xylene SCHEMBL28075710 0.75 ACHE (0.63) ACHETP53TDP1ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1654238-A1 2-AMINOPYRIMIDINE AND 2-AMINOPYRIDINE-4-CARBAMATES FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AMGEN INC. (US) 2006-05-10 EP disclosed
WO-2005009978-A1 2-AMINOPYRIMIDINE AND 2-AMINOPYRIDINE-4-CARBAMATES FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AMGEN INC. (US) 2005-02-03 WO disclosed